Latest news for health care topics. Include medical news , health insurance , therapy and vaccine news

Thursday, November 3, 2016

Research Analysts Set Expectations for NxStage Medical Inc.’s Q3 2017 Earnings (NXTM) : com-unik





As it stated in com-unik

Research Analysts Set Expectations for NxStage Medical Inc.'s Q3 2017 Earnings (NXTM)

Research Analysts Set Expectations for NxStage Medical Inc.'s Q3 2017 Earnings (NXTM)
Research Analysts Set Expectations for NxStage Medical Inc.'s Q3 2017 Earnings (NXTM)
NxStage Medical Inc. (NASDAQ:NXTM) – Equities research analysts at William Blair issued their Q3 2017 earnings per share (EPS) estimates for shares of NxStage Medical in a research note issued on Monday.William Blair analyst M. Kaczor expects that the firm will post earnings of $0.01 per share for the quarter.Several other research analysts have also recently weighed in on NXTM.


moreover from com-unik

NxStage Medical Inc. (NXTM) Stock Rating Upgraded by Zacks Investment Research

NxStage Medical Inc. (NXTM) Stock Rating Upgraded by Zacks Investment Research
NxStage Medical Inc. (NXTM) Stock Rating Upgraded by Zacks Investment Research
NxStage Medical Inc. (NASDAQ:NXTM) was upgraded by Zacks Investment Research from a "hold" rating to a "strong-buy" rating in a research note issued on Thursday.The firm currently has a $24.00 price objective on the medical device company's stock.Zacks Investment Research's price target indicates a potential upside of 13.37% from the stock's current price.


in addition pantagraph

NxStage Medical Sees Better Times Ahead

NxStage Medical Sees Better Times Ahead
NxStage Medical Sees Better Times Ahead
Already a subscriber?Click on the button below to set up your account or log in if you already have one.


in the same way fool

NxStage Medical Sees Better Times Ahead -- The Motley Fool

NxStage Medical Sees Better Times Ahead -- The Motley Fool
NxStage Medical Sees Better Times Ahead -- The Motley Fool
Home-dialysis specialist NxStage Medical (NASDAQ:NXTM) has worked hard toward making a profit, but it also hasn't hesitated to spend money in an effort to promote faster growth in the future.Coming into Thursday's third-quarter financial report, NxStage investors didn't expect the company to finish in the black, but they did hope that NxStage would give them some news they could feel optimistic about.NxStage didn't disappoint on that front, posting better sales and a narrower net loss than it had expected and also making favorable changes to its full-year guidance.


in the same way thecerbatgem

FY2017 EPS Estimates for NxStage Medical Inc. (NXTM) Lifted by William Blair

FY2017 EPS Estimates for NxStage Medical Inc. (NXTM) Lifted by William Blair
FY2017 EPS Estimates for NxStage Medical Inc. (NXTM) Lifted by William Blair
NxStage Medical Inc. (NASDAQ:NXTM) – William Blair raised their FY2017 earnings estimates for NxStage Medical in a research note issued on Monday.William Blair analyst M. Kaczor now anticipates that the brokerage will post earnings per share of ($0.03) for the year, up from their prior forecast of ($0.05).A number of other research firms have also recently issued reports on NXTM.


No comments:

Post a Comment